stockrowPrestige Consumer Healthcare Inc.
PBH Healthcare Drug Manufacturers Specialty & Generic
Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.
- Revenue
- +22.7%
- EPS
- −38.4%
- Free cash flow
- −38.2%
- Total debt
- +100.9%
Quarter to September 2026, against a year earlier
Follow PBH
Alert me
Prestige Consumer Healthcare Inc. (PBH) Net income
Prestige Consumer Healthcare Inc.'s net income for fiscal 2026 was $190.3M, down 11.3% from $214.6M in fiscal 2025. Over the twelve months to 30 September 2026 it was $155.1M. Over the past ten years it has ranged from −$82.3M (fiscal 2023) to $339.6M (fiscal 2018); the current reading is higher than 67% of that period. Prestige Consumer Healthcare Inc. ranks 12th of 84 Drug Manufacturers Specialty & Generic companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2026 | $190.3M | (11.32%) |
| FY2025 | $214.6M | 2.52% |
| FY2024 | $209.3M | — |
| FY2023 | −$82.3M | — |
| FY2022 | $205.4M | 24.71% |
| FY2021 | $164.7M | 15.74% |
| FY2020 | $142.3M | — |
| FY2019 | −$35.8M | — |
| FY2018 | $339.6M | 389.33% |
| FY2017 | $69.4M | (30.54%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $25.3M | (13.31%) |
| Jun 2026 | $29.2M | (45.90%) |
| Mar 2026 | $53.9M | 15.49% |
| Dec 2025 | $46.7M | 10.63% |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| HCM HUTCHMED (China) Limited Sponsored ADR compare | $967.7M |
| PBH Prestige Consumer Healthcare Inc. | $155.1M |
| XERS Xeris Biopharma Holdings, Inc. compare | −$6.5M |
| RGC Regencell Bioscience Holdings Limited compare | −$14.0M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −$152.1M |
| ALVO Alvotech compare | −$179.6M |
| BCRX BioCryst Pharmaceuticals, Inc. compare | −$359.7M |
| TRLV Trulieve Cannabis Corp. compare | −$446.6M |
| PRGO Perrigo Company plc compare | −$1.8B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on PBH
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement